Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.19.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Revenue    
Product revenue, net $ 6,125 $ 5,509
Revenue - from a related party 352 394
Net revenue 6,477 5,903
Operating expenses    
Cost of goods sold - product revenue 1,884 1,472
Research and development 23,273 24,958
Research and development - licenses acquired 450 97
General and administrative 13,478 13,548
Total operating expenses 39,085 40,075
Loss from operations (32,608) (34,172)
Other income (expenses)    
Interest income 438 278
Interest expense and financing fee (2,469) (2,403)
Change in fair value of derivative liability 0 23
Change in fair value of subsidiary convertible note 0 250
Change in fair value of investments 0 (118)
Gain on deconsolidation of Caelum 18,384 0
Total other income (expense) 16,353 (1,970)
Loss from continuing operations (16,255) (36,142)
Discontinued operations    
Loss from discontinued operations, net of tax 0 (2,076)
Total loss from discontinued operations 0 (2,076)
Net loss (16,255) (38,218)
Less: net loss attributable to non-controlling interests 17,647 17,200
Net income (loss) attributable to common stockholders $ 1,392 $ (21,018)
Loss from continuing operations per common share - basic and diluted $ (0.34) $ (0.85)
Loss from discontinued operations per common share - basic and diluted 0 (0.05)
Net income (loss) per common share attributable to common stockholders - basic 0.03 (0.49)
Net income (loss) per common share attributable to common stockholders - diluted $ 0.02 $ (0.49)
Weighted average common shares outstanding - basic 48,506,994 42,518,403
Weighted average common shares outstanding - diluted 63,811,136 42,518,403